echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The new crown vaccine of the Tibetan pharmaceutical industry mRNA has been approved clinically

    The new crown vaccine of the Tibetan pharmaceutical industry mRNA has been approved clinically

    • Last Update: 2021-01-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On January 5, Tibet Pharmaceuticals announced that for the new coronavirus pneumonia, the new crown vaccine products developed by the microorganisms involved in the cooperation based on its mRNA technology platform have been approved for clinical trials of the drug and will proceed with clinical trials as planned.
    based on vaccine research and development experience, clinical trial research has some risks.
    The progress and results of clinical trials are affected by, but are not limited to, trial scenarios, subject recruitment, outbreak development, and may be terminated due to issues such as the safety and/or effectiveness of clinical trials.
    in response to this new coronavirus pneumonia, the microbiome launched an emergency research and development project on the new coronary mRNA vaccine in January 2020 and completed the pharmacodynamic study of all candidate vaccines.
    , the vaccine has been clinically approved in China and clinical trials will be conducted as planned, overseas related work has not yet started, overseas declaration, registration, review, product launch in accordance with local laws and regulations.
    In accordance with the agreement, the Company has paid an advance payment of RMB 35 million (including tax) after the signing of the agreement, and rmb 35 million (including tax) will be paid to the microorganisms after obtaining the Pharmaceutical Clinical Trial Approval.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.